Sha***.D.

Senior Director Corporate Development

学歴

Max Planck Institute for Polymer Research

Max Planck Institute for Polymer Research (2013 - 2016)

  • Degree: Doctor of Philosophy (Ph.D.)
  • Field of Study: Chemistry
  • Description: Main focus: Complex Colloids Prepared by Emulsion Techniques For Biomedical applications Thesis Title: “Advanced Polymer Nanocapsules with Enhanced Capabilities for Controlled-Release of Payloads”

Harvard Business School Online (2021 - 2021)

  • Degree: Certificate in Disruptive Strategy
  • Field of Study: Unknown Field
  • Description:

Sharif University of Technology (2009 - 2012)

  • Degree: Master's degree
  • Field of Study: Materials Science and Engineering
  • Description: Main focus: Nanomaterials Fabrication and Characterization Thesis Title: “Synthesis and Biocompatibility Evaluation of Titanium Oxide/Pyrolytic Carbon Core/Shell Nanoparticles”

スキル:

Corporate Strategy, Business Development, Research and Development (R&D), Competitive Intelligence

職務経験:

Senior Director Corporate Development at ReAlta Life Sciences

  • Location: Virginia, United States
  • Duration: 2024-07 to Present
  • Description: ReAlta Life Sciences is a clinical stage company focused on inflammatory diseases. Our platform presents a novel opportunity to modify disease progression through moderation of the most robust components of both humoral (complement system) and cellular (neutrophils) components of innate inflammatory responses

Director of Strategy & Business Development at Ginkgo Bioworks, Inc.

  • Location: Boston, Massachusetts, United States
  • Duration: 2023-07 to 2024-06
  • Description: As a Director of Corporate Strategy & BD, I scout new areas where Ginkgo’s cell therapy platform is ripe to be a disruptive technology and introduce that expertise to prospective pharma / biotech partners. I distill information from prospective partner conversations and secondary sources and advance this thinking into specific deal concepts that meet partner needs and utilize Ginkgo’s capabilities / assets to its fullest potential. As deals progress, I shepherd them closely, but also keep an eye on the big picture and ensure that our team priorities are focused on the best fit and highest likelihood opportunities

Associate Director, Corporate and Business Development at Senda Biosciences

  • Location: Greater Boston
  • Duration: 2022-04 to 2023-07
  • Description: As a Senior Manager and later as an Associate Director of Corporate & Business Development, I excel at creating corporate/BD strategy by actively leading / participating in variety of activities. I frequently generated strategic insights based on best-in-class analysis, and distilled outputs and recommendations which enabled informed decisions of top-level leaders. I have built investor presentations and created corporate messages for Series B and C funding rounds, resulting in ~$225 M investment. To fulfill these activities, I partnered with the Heads of the Corporate, R&D, Translational Medicine, and Finance teams as I led Senda’s Business Intelligence team and managed the “Pipeline Creation” workstream. Regarding BD efforts, I drove several strategic partnership cases for Senda including out-licensing and co-development agreements. In fact, I partnered with the Head of the BD team to map and prioritize external opportunities in emerging areas that address Senda’s portfolio gaps and support value creation.

Senior Manager, Corporate and Business Development at Senda Biosciences (A Flagship Pioneering Company)

  • Location: Greater Boston
  • Duration: 2021-04 to 2022-03
  • Description:

Life Sciences Consultant at ClearView Healthcare Partners

  • Location: Greater Boston Area
  • Duration: 2019-03 to 2021-03
  • Description: As a Life Sciences Consultant at ClearView Healthcare Partners in Boston, I honed my strategic consulting expertise in the life sciences sector. My experience in the life science space ranges from R&D to commercial and marketing strategy. I have enjoyed adding value to several engagements where clients primarily included Fortune 100, mid-cap, and private biotech companies. I performed indication opportunity assessment, extensive due diligence, therapeutic area strategy, and prepared strategic plans to address unmet medical needs across several therapeutic areas including cell & gene therapy, oncology, immunology, CNS, cardiology, etc.
AI履歴書分析

候補者インテリジェンスレポート

米国の採用ディレクターの視点からAI分析 — キャリアの継続性、成長軌道、および役職適合性を評価します。

キャリアの継続性とリスク評価

Employment GapLow

The candidate has a continuous work history from 2019 to present with immediate transitions between roles, indicating no reported employment gaps.

Industry ConsistencyLow

All roles are within the life sciences/biotech sector (consulting, strategy/BD, and R&D ecosystem), including biotech startups and large platforms, which shows strong industry consistency.

Tenure StabilityMedium

Most prior roles are around 12 months in duration with a pattern of moving to higher responsibilities; while the current role has extended into multiple years, the past shorter tenures suggest moderate stability risk for long-term tenure.

Education-Career MatchLow

Ph.D. and postdoctoral work in nanoparticle-based drug delivery from premier institutions align well with senior BD/strategy roles in biotech, enhancing credibility and domain expertise.

キャリア成長カーブ

Life Sciences Consultant Entry
ClearView Healthcare Partners
2019-03 to 2021-03
Senior Manager, Corporate and Business Development ↑ 昇進
Senda Biosciences (Flagship Pioneering)
2021-04 to 2022-03
Associate Director, Corporate and Business Development ↑ 昇進
Senda Biosciences
2022-04 to 2023-07
Director of Strategy & Business Development ↑ 昇進
Ginkgo Bioworks
2023-07 to 2024-06
Senior Director Corporate Development ↑ 昇進
ReAlta Life Sciences
2024-07 to Present
評価:The candidate exhibits a clear upward trajectory with progressively broader responsibility in biotech corporate strategy, BD, and fundraising. The pattern suggests readiness for senior leadership roles (VP/CSO-level) overseeing strategy, alliances, and portfolio development in biotech/pharma.

最適な役職(トップ5)

1

Vice President, Corporate Development96% 適合

Proven track record leading corporate/BD strategy, complex partnerships, and fundraising across multiple biotech platforms; strong cross-functional leadership and ability to shape portfolio strategy at scale.

2

Senior Vice President, Strategy & Corporate Development92% 適合

Extensive experience drafting and executing strategic initiatives at the intersection of R&D, translational medicine, and external partnerships; aligns with senior executive expectations for portfolio optimization.

3

Head of Strategic Partnerships90% 適合

Deep experience in partner search/evaluation, co-development/out-licensing, and deal structuring; suitable for a role focused on external collaborations and pipeline strategy.

4

Chief Strategy Officer88% 適合

Capabilities in corporate/portfolio strategy, fundraising narrative, and investor communications; well-suited for leading company-wide strategic direction in a growth-stage biotech.

5

Director/VP, BD & Portfolio Strategy85% 適合

Strong BD and portfolio-building background with cross-functional leadership; could drive early-stage to late-stage value creation in a mid-cap biotech.

AI Recruiterを体験する

無料で始めましょう。ライバルに先を越されないでください。

AI駆動の採用ソリューションを活用して、採用プロセスを自動化し、時間コストの80%を削減している10,000社以上の企業に加わりましょう。

33%オフ、残り48時間のみ!
AIを無料で試す

24時間365日自動運用

AIを活用した候補者スクリーニング

地理的・時差の制限なく採用活動

パーソナライズされたインテリジェントコミュニケーション

候補者エンゲージメントの自動評価

あなたの採用スタイルをインテリジェントに模倣・再現

4ヶ月間の返金保証

LinkedInアカウントのセキュリティを確保